AzTrials
AzTrials

Critically Ill PatientsCARTOFLNCT07837843

Capillary Refill Time Variation to Predict Oxygen Comsumption Variation After FLuid Challenge (CARTOFL)

An observational study of Critically Ill Patients and Circulatory Shock, run by Hospices Civils de Lyon at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Circulatory shock is characterized by tissue hypoxia. Although fluid resuscitation is an essential treatment in many forms of circulatory shock, its benefits are variable, and its administration carries a risk of potentially harmful fluid overload. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Indirect calorimetry measurement
Type of treatment
Medical device
How many people
80 participants
Where
1 siteFrance
Study dates
1 Dec 2026to 1 Dec 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients admitted to the ICU

Who may be able to join

  • Adult patient admitted to the intensive care unit within the previous 72 hours
  • Receiving invasive mechanical ventilation
  • For whom the clinician plans to perform a fluid challenge
  • No objection from the participant or a relative/legally authorized representative

Who cannot join

  • Fraction of inspired oxygen greater than 60%
  • Administration of inhaled medications, including nitric oxide
  • Positive end-expiratory pressure greater than 15 cmH₂O
  • Excessive leaks in the ventilator circuit, defined as an expired volume less than 95% of the inspired volume
  • Patient receiving mechanical circulatory support involving a gas exchanger
  • Patient receiving renal replacement therapy
  • Administration of sodium bicarbonate within the 2 hours preceding inclusion
  • Disconnection from the ventilator anticipated before the end of the study

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Rémi Schweizer, Dr contact

0033472357093

remi.schweizer@chu-lyon.fr

France1 site
  • Service d'Anesthésie-Réanimation, Hôpital Louis Pradel, Hospices Civils de Lyon

    Bron, 69500

    Rémi Schweizer, Dr, 0033472357093, remi.schweizer@chu-lyon.fr

    Rémi Schweizer, Dr

Other trials in France

About this study

Circulatory shock is characterized by tissue hypoxia. Although fluid resuscitation is an essential treatment in many forms of circulatory shock, its benefits are variable, and its administration carries a risk of potentially harmful fluid overload.

Assessment of fluid responsiveness generally relies on changes in cardiac output. However, the actual therapeutic objective is rather to improve tissue oxygen utilization, as reflected by oxygen consumption. Despite its physiological relevance, direct measurement of oxygen consumption remains complex and difficult to perform in routine clinical practice.

Read more

Capillary refill time is a simple, rapid, non-invasive, and readily available marker of peripheral perfusion. It is associated with outcomes in patients with circulatory shock, and a capillary refill time-guided therapeutic strategy may improve outcomes in patients with septic shock.

This study hypothesizes that changes in capillary refill time following fluid resuscitation may predict changes in oxygen consumption induced by fluid administration. If confirmed, capillary refill time and its changes could be incorporated into the criteria used to assess the indication for fluid resuscitation in patients with shock. They would also provide additional physiological information regarding the relationship between peripheral perfusion and oxygen consumption.

Being tested
Indirect calorimetry measurement
Keywords
ICU, Circulatory shock, Oxygen consumption, Fluid responsiveness, Capillary refill time
Medical subject headings
Shock

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Indirect calorimetry measurementDevice

    Setup of an indirect calorimetry measurement

Study groups in NCT07837843
Study groupRoleWhat they receive
PatientsThe patients targeted by this study are mechanically ventilated intensive care patients for whom the attending clinician plans to perform a fluid challenge.
Receives: Device: Indirect calorimetry measurement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessment of the ability of fluid challenge-induced changes in capillary refill time to predict fluid challenge-induced changes in oxygen consumption

    Area under the receiver operating characteristic curve of changes in capillary refill time for predicting a 15% increase in oxygen consumption during a fluid challenge

    Measured: Day 0

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Sep 2026
  2. Study start1 Dec 2026 (estimated)
  3. Primary completion1 Dec 2027 (estimated)
  4. Study completion1 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07837843
Sponsor's protocol ID
69HCL26_0902
Acronym
CARTOFL
Status last verified
Sep 2026
First submitted
15 Sep 2026
Last updated
24 Sep 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Critically Ill Patients and Circulatory Shock, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 24 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Rémi Schweizer, Dr (0033472357093, remi.schweizer@chu-lyon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessment of the ability of fluid challenge-induced changes in capillary refill time to predict fluid challenge-induced changes in oxygen consumption (time frame: Day 0). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in